Reminder: Levi & Korsinsky Issues Class Action Lawsuit Alert for Zenas BioPharma, Inc.
A class-action lawsuit alert has been issued by Levi & Korsinsky for investors in Zenas BioPharma, Inc. (ZBIO), reminding them of the upcoming deadline on June 16, 2025. This legal action is being taken in response to alleged violations of federal securities laws by Zenas BioPharma, Inc.
Investors who purchased shares of Zenas BioPharma, Inc. are encouraged to participate in the lawsuit, which aims to hold the company accountable for any misleading or false statements that may have impacted the stock price. The deadline of June 16, 2025, should be noted by all shareholders who wish to be included in the class action lawsuit.
Levi & Korsinsky is a well-known law firm that specializes in representing investors in securities litigation. The firm has a strong track record of successfully fighting for the rights of shareholders who have been harmed by corporate misconduct. By alerting Zenas BioPharma, Inc. investors of the upcoming deadline, Levi & Korsinsky is providing them with the opportunity to seek justice and possibly recover any financial losses they may have suffered.
Class-action lawsuits are a powerful tool for holding companies accountable for their actions and ensuring that investors are protected. By joining together in a collective legal action, shareholders can increase their chances of obtaining a favorable outcome and holding Zenas BioPharma, Inc. responsible for any deceptive practices that may have harmed investors.
If you are an investor in Zenas BioPharma, Inc. and believe that you may have been impacted by the company’s actions, it is important to take action before the June 16, 2025 deadline. By participating in the class-action lawsuit, you can join forces with other shareholders and seek justice for any financial losses you may have experienced as a result of the alleged securities law violations.
Levi & Korsinsky’s alert serves as a reminder to Zenas BioPharma, Inc. investors of the impending deadline and the opportunity to seek justice through legal action. Investors who believe they have been affected by the company’s actions should consider taking part in the class-action lawsuit to assert their rights and hold Zenas BioPharma, Inc. accountable for any misleading or false statements that may have impacted their investments.